$92.94
▲ +0.7% Today
as of Jul 22, 10:16 ET
Last 30 days
Recent Press Releases & News
BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026
Arbutus Biopharma, Genevant sue Pfizer, BioNTech Over Lipid Nanoparticle Patents
Analyst Report: BioNTech SE
Overview
52-week range
$80
$124
30% of range
Avg surprise (last 3)
+1.6%
Avg reaction (last 2)
-3.8%
0% positive
Latest IV / EM
48%
EM ±11.2% · $93 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $-2.28 | $-2.52 | +9.5% | -25.3% | -3.9% | earnings |
| Mon Aug 4, 2025 | Jun/2025 | $-1.82 | $-1.31 | -38.9% | — | — | earnings |
| Mon May 5, 2025 | Mar/2025 | $-1.82 | $-2.77 | +34.3% | — | -3.7% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | BMO | -$2.58 | -$1.82 | -41.8% |